Lung cancer treatment firm Broncus sinks in Hong Kong debut

Broncus Holding

24/09/2021 05:37

** Shares of lung cancer treatment solutions provider
Broncus Holding Corp  2216.HK  fall as much as HK$ 14.66 in Hong
Kong debut on Friday, down 21.6% from the offer price 
    ** Stock last trades at HK$15.28, down 18.2% from the offer
price of HK$18.70 
    ** Zhejiang, China-based co offered 89.36 mln shares in its
IPO, raising HK$1.67 bln ($214.6 mln) to fund R&D and commercial
launches of products, and for expansion of manufacturing
facilities and product portfolio  urn:newsml:reuters.com:*:nFWN2QO0YI
    ** The Hang Seng Commerce & Industry Index  .HSNC  gains
0.1% while the healthcare index  .HSCIH  slips 0.2%
    ** The Hang Seng China Enterprises Index  .HSCE  eases 0.2%
and the benchmark index  .HSI  is down 0.03%

($1 = 7.7832 Hong Kong dollars)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))